Invest and Sell Aledade Stock

Aledade stock price

Forge Price ¹

Price not yet available

Last Closed Trade ²

Close Date

xx/xx/xx

Last Closed Trade Price

$xx.xx

Last Funding Round (LFR)

Date

xx/xx/xx

Price per Share

$xx.xx

Access Stock Price

Aledade funding rounds and valuation

Funding history chart

Funding round details

	Funding Date	Share Class	Amount Raised	Price per Share	Post-Money Valuation	Key Investors
	06/21/2023	Series F	$260MM	$xx.xx	$3.52B	Avidity Partners, Fidelity, Lightspeed Venture Partners, Omers Growth Equity, Venrock
Price per Share $xx.xx Shares Outstanding 5,187,804 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Avidity Partners, Fidelity, Lightspeed Venture Partners, Omers Growth Equity, Venrock
	06/06/2022	Series E-1	$92.27MM	$xx.xx	$3.14B	Fidelity, Omers Growth Equity
Price per Share $xx.xx Shares Outstanding 1,852,227 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Fidelity, Omers Growth Equity
	06/06/2022	Series E-3	$30MM	$xx.xx	$3.14B	Fidelity, Omers Growth Equity
Price per Share $xx.xx Shares Outstanding 602,235 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Fidelity, Omers Growth Equity
	06/06/2022	Series E-2	$10.29MM	$xx.xx	$3.14B	Fidelity, Omers Growth Equity
Price per Share $xx.xx Shares Outstanding 242,984 Liquidation Pref Order 1 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Fidelity, Omers Growth Equity
	01/19/2021	Series D	$100.25MM	$xx.xx	$2.37B	Ivp, Meritech Capital Partners, Omers Growth Equity, Tiger Global Management
Price per Share $xx.xx Shares Outstanding 2,618,130 Liquidation Pref Order 2 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Ivp, Meritech Capital Partners, Omers Growth Equity, Tiger Global Management
	04/20/2020	Series C	$67.33MM	$xx.xx	$735.89MM	California Medical Association, Cvf, Echo Health Ventures, Gv, Meritech Capital Partners, Omers Growth Equity
Price per Share $xx.xx Shares Outstanding 5,206,094 Liquidation Pref Order 3 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors California Medical Association, Cvf, Echo Health Ventures, Gv, Meritech Capital Partners, Omers Growth Equity
	01/18/2019	Series B-2	$56.15MM	$xx.xx	$411.08MM	Echo Health Ventures, Meritech Capital Partners
Price per Share $xx.xx Shares Outstanding 7,126,806 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Echo Health Ventures, Meritech Capital Partners
	03/08/2017	Series B-1	$45.25MM	$xx.xx	$207.68MM	Arch Venture Partners, Biomatics Capital, Gv, Maryland Venture Fund, Mckesson Ventures, Venrock
Price per Share $xx.xx Shares Outstanding 8,262,765 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Arch Venture Partners, Biomatics Capital, Gv, Maryland Venture Fund, Mckesson Ventures, Venrock
	06/15/2015	Series B	$30.25MM	$xx.xx	$135.88MM	Arch Venture Partners
Price per Share $xx.xx Shares Outstanding 5,954,491 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Arch Venture Partners
	06/18/2014	Series A	$5.04MM	$xx.xx	$16.79MM	Venrock
Price per Share $xx.xx Shares Outstanding 4,744,293 Liquidation Pref Order 4 Liquidation Pref As Multiplier 1.0x Conversion Ratio 1.0x Dividend Rate 0.0% Cumulative Non-cumulative Participating Non-participating Participation Cap -- Key Investors Venrock

Access Stock Price

Aledade stock FAQs

To buy and sell Aledade stock

Can you buy Aledade stock?

As Aledade is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like Aledade, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy Aledade stock?

To invest in a private company like Aledade through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Aledade stock?

Yes, you may sell the Aledade stock you currently own. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Aledade stock?

If you hold private company shares of Aledade – whether as an employee or an early investor – Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Aledade on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

To learn more about Aledade stock

Is Aledade a public company?

No, Aledade is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Aledade’s stock price?

Aledade is a privately held company and therefore does not have a public stock price. However, you may access Aledade private market stock price with Forge Data.

What is Aledade’s stock ticker symbol?

Aledade does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Leadership and board

Leadership

Mandy Cohen

Executive Vice President & Chief Executive Officer, Aledade Care Solutions

Farzad Mostashari MD

Co-Founder & Chief Executive Officer

Mat Kendall

Co-Founder & President

Douglas Street

Chief Operating Officer of Aledade Care Solutions & Chief of Staff

Ritwik Tewari

Chief Technology Officer

Phuong Phillips

Chief Legal Officer

Ahmed Haque

Chief Performance Officer

Nick Kinkaid

Chief Product Officer

Ananya Banerjee

Chief Commercial Officer

Emily Maxson MD

Chief Medical Officer

John Doyle

Chief Financial Officer

Dan Bowles

Chief Growth Officer

Sean Cavanaugh

Chief Policy Officer

Board

Julie Sunderland

Biomatics Capital

Robert Kocher MD

Venrock

Aledade news and media highlights

Medium 06/21/2023

Why Lightspeed is Leading Aledade’s Series F

When we first met Aledade, co-founder and CEO Dr. Farzad Mostashari invited us to learn about the company, but also left us with a polite, albeit straightforward warning: this is a complex business, and we’d have to put in the work to understand the opportunity. We’re glad we accepted the challenge, and we are excited to lead Aledade’s $260M Series F financing round.

Bloomberg.com 06/21/2023

Aledade Raises $260 Million to Help Doctors Change How They Practice

Aledade, a company that helps US doctors adapt their practices to new payment arrangements aimed at improving care and cutting costs, raised $260 million in venture capital to expand its network. The deal values the company at $3.5 billion, according to people familiar with the situation, with investors buying in on similar terms to the company’s most recent funding round last year.

Business Wire 03/02/2023

Humana and Aledade Announce 10 Year Collaboration

Aledade, the nation’s largest network of independent primary care, and Humana Inc. (NYSE: HUM), leading health insurer and health care services company, have announced a 10-year collaboration to provide value-based primary care for Humana’s Medicare Advantage members from in-network Aledade-enabled physicians.

Business Insider 01/19/2021

Aledade just raised $100 million in a round that values the primary-care startup at $2.1 billion. Here's the presentation that won over investors.

The primary-care startup raised $100 million in funding, which will be used to expand into more states and grow its footprint in Medicare Advantage.

Other companies like Aledade in the Healthcare providers & services sector

Sector: Healthcare

Subsector: Healthcare providers & services

					Last Funding Round
Company		Forge Price	Forge Price Change ⁵	Last Closed Trade	Share Class	Post-Money Valuation	Price per Share	Amount Raised
	Carrot	--	--	$xx.xx	Series D	$611.49MM	$xx.xx	$50MM
	Collective Health	$0.19	-5.00%	$xx.xx	Series F	$1.53B	$xx.xx	$280MM
	Dandy	--	--	$xx.xx	Series Seed-1	$10.41MM	$xx.xx	$2.63MM
	Devoted Health	--	--	$xx.xx	Series E	$13.03B	$xx.xx	$287MM
	Digital Diagnostics	--	--	$xx.xx	Series B	$286.24MM	$xx.xx	$76.39MM
	Galileo Health	--	--	$xx.xx	Series E	$550.62MM	$xx.xx	$50MM
	HeartFlow	--	--	$xx.xx	Series E	$1.65B	$xx.xx	$305MM
	Mark Cuban Cost Plus Drug Company	--	--	$xx.xx	--	--	--	--
	Medline Industries	--	--	$xx.xx	--	--	--	--
	NowRx	--	--	$xx.xx	Series C	$334.19MM	$xx.xx	$74.03MM

See All Companies

Forge is your trusted partner to buy and sell Aledade stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

First time buying private market stock?

New to selling your private company stock?

Updated on: Feb 13, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.

Aledade stock